fig5

Impact of genetic variants in the solute carrier (<i>SLC</i>) genes encoding drug uptake transporters on the response to anticancer chemotherapy

Figure 5. Relationship between genetic variants of pharmacologically relevant members of the SLC family 31, substrate drugs affected by changes in these proteins, and cancers treated with these compounds. SLC: Solute carrier.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/